Hagedorn, Martin <br/><br/>
Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.  [electronic resource] 

 -  Cancer research  Dec 2002 
 - 6884-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Allantois--blood supply<br/>Amino Acid Sequence<br/>Angiogenesis Inhibitors--chemistry<br/>Animals<br/>Aorta--drug effects<br/>Brain Neoplasms--blood supply<br/>Cattle<br/>Cell Division--drug effects<br/>Cell Movement--drug effects<br/>Chick Embryo<br/>Chorion--blood supply<br/>Endothelial Growth Factors--antagonists & inhibitors<br/>Endothelium, Vascular--cytology<br/>Female<br/>Fibroblast Growth Factor 2--antagonists & inhibitors<br/>Glioma--blood supply<br/>Humans<br/>In Vitro Techniques<br/>Intercellular Signaling Peptides and Proteins--metabolism<br/>Lymphokines--antagonists & inhibitors<br/>Male<br/>Mice<br/>Mice, Nude<br/>Molecular Sequence Data<br/>Neovascularization, Pathologic--drug therapy<br/>Neovascularization, Physiologic--drug effects<br/>Peptide Fragments--chemistry<br/>Platelet Factor 4--chemistry<br/>Protein Structure, Tertiary<br/>Rats<br/>Rats, Sprague-Dawley<br/>Structure-Activity Relationship<br/>Vascular Endothelial Growth Factor A<br/>Vascular Endothelial Growth Factors<br/>Xenograft Model Antitumor Assays